A multinational research team led by Columbia University and the La Jolla Institute for Immunology has identified a novel viral target that could help combat the global resurgence of measles.
A new study shows that an ancient mechanism of regulating a cell’s protein repertoire allows malaria parasites to hide from fast-acting artemisinin drugs and survive.
Columbia University bioethicist Maya Sabatello says a Truth and Reconciliation Commission is needed to confront the structural racism in health care (and society) highlighted by the COVID-19 pandemic.
Cancer patients are especially vulnerable to COVID and would benefit from the protection the vaccine offers, says Gary Schwartz, MD, deputy director of the Herbert Irving Comprehensive Cancer Center.
A strategic decision-making and team-building exercise for hospital executives—developed at Columbia University Mailman School of Public Health—now includes a simulated pandemic.
Viral load, the amount of virus detected in a PCR nasal swab, can be used to predict patient outcomes and guide quarantine decisions, Daniel Griffin says.
When the virus arrived in New York City, VP&S clinicians were redeployed to areas in need, researchers pivoted to COVID research, and students graduated early to help “bend the curve.”
Front-line physicians, nurses, and staff at Columbia University Irving Medical Center have begun receiving the initial doses of the first COVID vaccines.
A study of more than 1 million patients has found no increased risk of COVID-19 diagnosis, hospitalization, or complications for users of two common anti-hypertensive medications.
Researchers at Columbia, UCLA, and Northeastern have begun helping the FDA in its effort to monitor the safety and effectiveness of vaccines, including COVID-19 vaccines, and other biologic products.
Columbia’s Evelyn Berger-Jenkins, MD, has co-authored new recommendations to help pediatricians address emotional and behavioral health issues in children during the COVID-19 pandemic.